Actively Recruiting
Led by University of Sao Paulo General Hospital · Updated on 2025-10-03
480
Participants Needed
2
Research Sites
26 weeks
Total Duration
U
University of Sao Paulo General Hospital
Lead Sponsor
I
Instituto Dante Pazzanese de Cardiologia
Collaborating Sponsor
Cardiovascular diseases remain the leading cause of death worldwide, with coronary artery disease being a major contributor, especially in Brazil. Coronary artery bypass grafting (CABG) is a common treatment for this condition, primarily funded by Brazil's Unified Health System. While cardiac surgery outcomes have improved due to quality programs, these improvements are not yet consistent nationwide. This research investigates the impact of a technology platform based on the Enhanced Recovery After Surgery (ERAS) concept to improve recovery after CABG and support healthcare sustainability in São Paulo. The trial compares two approaches for patients undergoing CABG: standard care as practiced by each participating institution and a modified protocol based on ERAS supported by a digital platform. The digital platform assists patients from before surgery through 30 days after discharge, including pre-operative evaluations, hospital admission scheduling, surgical protocols, and intensive care processes. The platform also enhances communication among healthcare teams and between patients and providers, using educational modules, messaging, surveys, and a dashboard to monitor protocol adherence and patient outcomes. Participants will be monitored for up to 30 days after surgery to assess hospital length of stay, with additional follow-up up to six months for morbidity, mortality, and patient-reported outcomes and experiences. The study involves evaluations of protocol step completion during the first week post-surgery and gathers data on patient recovery and satisfaction. This comprehensive monitoring aims to understand how the ERAS-based digital platform influences recovery and healthcare value after CABG.
CONDITIONS
Impact of a Technology Platform Based on Enhanced Recovery After(ERAS) Surgery on Length of Stay After Coronary Artery Bypass Grafting: Timely Project
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Up to hospital discharge
Participants undergo coronary artery bypass grafting surgery and receive immediate post-operative care following either standard care or an enhanced recovery protocol supported by a digital platform.
1 surgery visit and in-hospital care
Duration - Up to 6 months after surgery
Participants are followed for recovery and outcomes including length of hospital stay, protocol adherence, morbidity, mortality, and patient-reported outcomes up to 6 months after surgery.
Visits and interactions through the digital platform and clinical follow-ups as scheduled
Total: 2 locations
1
InCor - Instituto do Coração do Hospital das Clínicas da FMUSP
São Paulo, São Paulo, Brazil, 05403-900
Actively Recruiting
2
InCor - Instituto do Coração do Hospital das Clínicas da FMUSP
São Paulo, São Paulo, Brazil, 05403-900
Not Yet Recruiting
O
Omar A V Mejia, MD, PhD
P
Pedro H Reis, MD
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
HEALTH_SERVICES_RESEARCH
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Gabrielle Barbosa Borgomoni, Pedro Horigoshi Reis, Guilherme Pinheiro...
https://pubmed.ncbi.nlm.nih.gov/41474739